Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine to Augment Intensive CBT for Pediatric OCD
NCT01687140Phase 2Unknown
- Sponsor
- University of California, Los Angeles
- Start
- Jul 2012
- Primary completion
- Jul 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing Placebo with DCS (2 arms). Primary endpoint: Children's Yale Brown Obsessive Compulsive Scale. Status: unknown.
02
Drugs
d-cycloserine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT01687140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01687140.